by Scott Larrivee | Oct 16, 2025 | News
The following is a copy of a press release issued by Clarity Pharmaceuticals Sydney, Australia 16 October 2025 Clarity Pharmaceuticals (ASX: CU6) (“Clarity” or “Company”), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products...
by Scott Larrivee | Feb 5, 2025 | Podcast
On this episode, Talk Radioisotopes hosts Scott Larrivee and Sarah Scouten sit down with Shaemus Gleason, Executive Vice President at Clarity Pharmaceuticals. The discussion highlights Shaemus’s journey through the radiopharmaceutical industry, Clarity’s...
by Scott Larrivee | Jul 10, 2024 | News
VALENCIA, Calif. and BOCA RATON, Fla. – July 10, 2024 – Nusano Inc. (Nusano), a physics company transforming the production of medical radioisotopes, and PharmaLogic Holdings Corp. (PharmaLogic), a leading radiopharmaceutical contract development and manufacturing...
